Cryo-Cell International
CCEL
13 hedge funds and large institutions have $4.45M invested in Cryo-Cell International in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 12 → 13 (+1)
0% more capital invested
Capital invested by funds: $4.44M → $4.45M (+$15.7K)
0.14% more ownership
Funds ownership: 8.79% → 8.92% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPWT
MassMutual Private Wealth & Trust
Windsor,
Connecticut
|
+$308K |
| 2 |
BlackRock
New York
|
+$77.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$14.1K |
| 4 |
Morgan Stanley
New York
|
+$2.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
-$332K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$32K |
| 3 |
ICM
ISZO Capital Management
New York
|
-$24.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.42K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
CCEL Hedge Fund Activity: Q2 2022 in Review
13 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q2 2022, worth a combined $4.45M — up 0.35% from $4.44M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CCEL positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was MassMutual Private Wealth & Trust, adding an estimated $308K. The largest seller was Seizert Capital Partners, exiting entirely with an estimated $332K sold.
- 13 institutional investors held Cryo-Cell International (CCEL) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $4.45M of Cryo-Cell International stock for Q2 2022, up 0.35% quarter-over-quarter.
- 2 funds opened new Cryo-Cell International positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest Cryo-Cell International buyer in Q2 2022 was MassMutual Private Wealth & Trust, an estimated $308K added.
- The largest Cryo-Cell International seller in Q2 2022 was Seizert Capital Partners, an estimated $332K sold.
Based on aggregated 13F filings for Q2 2022.